Polymixin B
No structure available
Polymixin B could not be matched to a single known compound.
Background
Listing
- Schedules
- Schedule 1 to 4, conditions apply
- Source
- Consolidated Schedules 06 July 2026
Registered medicines
The ingredient index links no registered medicine to Polymixin B (register of 13 September 2026).
Counted through the register's ingredient index, which does not reach every record.
Regulatory status
Where S1 to S4 sits on the scale
Depends on which listing applies
At the least restrictive, Schedule 1: sold by a pharmacist, no doctor's prescription needed. At the most restrictive, Schedule 4: prescription-only medicine. The listings below say which applies to which form, strength or pack size.
Schedule S1 to S4, as the Consolidated Schedules list it.
Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.
Consolidated Schedules listings for Polymixin b
S4: Polymixin B
- except when intended for topical application to the epidermis, nares and external ear.
Consolidated Schedules 06 July 2026, line 7603
S1: Polymixin B
- when intended for topical application to the epidermis, nares or external ear.
Consolidated Schedules 06 July 2026, line 1027
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.